The Chemours Company
CC
$11.72
$0.040.34%
NYSE
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 109.12% | 136.97% | 124.61% | 233.33% | -167.28% |
| Total Depreciation and Amortization | 2.68% | -1.95% | -3.26% | -2.32% | 1.01% |
| Total Amortization of Deferred Charges | 20.00% | 33.33% | 50.00% | 22.22% | 11.11% |
| Total Other Non-Cash Items | 144.38% | 114.79% | 138.36% | -103.70% | -244.90% |
| Change in Net Operating Assets | -251.81% | -270.16% | -291.12% | -359.15% | 599.14% |
| Cash from Operations | -216.67% | -213.85% | -222.98% | -173.33% | -38.00% |
| Capital Expenditure | 10.24% | 2.70% | -27.81% | -37.50% | -30.48% |
| Sale of Property, Plant, and Equipment | -100.00% | -40.00% | -223.81% | -- | 900.00% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | 762.50% | -- | 762.50% |
| Other Investing Activities | 100.00% | 300.00% | -88.24% | 187.50% | -66.67% |
| Cash from Investing | -45.06% | -54.15% | -129.27% | 17.91% | 14.02% |
| Total Debt Issued | -9.81% | -9.34% | -85.42% | 407.24% | 505.47% |
| Total Debt Repaid | -52.90% | -59.79% | 73.77% | -68.10% | -96.53% |
| Issuance of Common Stock | -55.56% | -52.63% | -50.00% | 50.00% | -61.70% |
| Repurchase of Common Stock | 96.55% | 96.59% | 98.28% | 92.52% | 84.94% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 0.67% | 0.67% | 0.00% | 1.99% | 1.32% |
| Other Financing Activities | 466.67% | 466.67% | 625.00% | -- | -50.00% |
| Cash from Financing | -120.97% | -120.93% | -800.00% | 143.86% | 132.92% |
| Foreign Exchange rate Adjustments | 36.36% | -650.00% | -54.55% | -1,200.00% | 35.29% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -352.71% | -307.55% | -1,088.61% | 19.11% | 248.21% |